Responsible AI Platform
All obligations
Applicablev1.0.0

Article 60: testing in real world conditions outside a sandbox

If you want to test an Annex III high-risk AI system with real people and real outcomes before placing it on the market, a full regime applies: a plan, prior approval by the market surveillance authority, registration, informed consent and a maximum duration.

The official source remains authoritative. This general interpretation is not legal advice.

Status
Applicable
Application date
2 August 2026
Version
1.0.0
Last reviewed
8 August 2026

Who this is relevant to

When this applies

  • Deployer

    An organisation using an AI system under its authority, excluding personal non-professional use.

  • Provider of an AI system

    A party that develops or has an AI system developed and places it on the market under its own name.

  1. 1Applies where you are a provider or prospective provider of an Annex III high-risk AI system and you want to test it in real world conditions outside an AI regulatory sandbox, before placing it on the market or putting it into service. If you are established outside the Union, Article 60(4), point (d), requires you to appoint a legal representative established in the Union; that is a different figure from the authorised representative under Article 22.

What the official source establishes

Article 60(1) provides that testing of high-risk AI systems in real world conditions outside AI regulatory sandboxes may be conducted by providers or prospective providers of high-risk AI systems listed in Annex III, in accordance with that Article and the real-world testing plan, without prejudice to the prohibitions under Article 5. The Commission specifies the detailed elements of that plan by implementing act. The third subparagraph of paragraph 1 provides that the paragraph is without prejudice to Union or national law on the testing in real world conditions of high-risk AI systems related to products covered by the Union harmonisation legislation listed in Annex I. Article 60(2) allows providers or prospective providers to test at any time before placing on the market or putting into service, on their own or in partnership with one or more deployers or prospective deployers. Article 60(3) provides that such testing is without prejudice to any ethical review required by Union or national law. Article 60(4), point (f), caps the duration: no longer than necessary to achieve its objectives and in any case no longer than six months, which may be extended by an additional six months subject to prior notification to the market surveillance authority with an explanation of the need. Article 60(4), point (g), requires that subjects belonging to vulnerable groups due to age or disability are appropriately protected. Article 60(9) expressly states that the provider or prospective provider remains fully subject to applicable Union and national law on any damage caused in the course of their testing in real world conditions. Chapter VI, which contains Article 60, is not among the exceptions in Article 113 and applies since 2 August 2026.

Our interpretation

Many organisations call what they do a pilot and assume that keeps them outside the Regulation. Article 60 shows that this does not hold once you test an Annex III system in real world conditions with real people and real outcomes. A full regime then applies: a plan, prior approval, registration with a Union-wide unique single identification number, informed consent, and a hard six-month clock with a maximum six-month extension. The heaviest requirement in practice is Article 60(4), point (k): the predictions, recommendations or decisions of the system must be capable of being effectively reversed and disregarded. If you are testing a selection, scoring or triage system whose output feeds straight into the workflow with nobody able to reverse it, your design does not qualify, however careful your consent form is. Note the timing too, because it is commercially interesting. Chapter VI applies since 2 August 2026, while the core obligations for standalone Annex III systems only apply from 2 December 2027. The testing route is therefore open before the requirements themselves bite, and that is exactly the window in which to validate your design rather than rebuild it later. Finally, Article 60(3) leaves any ethical review required under other law fully in place, and Article 60(9) expressly states that you remain fully subject to the applicable law on damage caused during the testing.

What you can do now

Inventory which running or planned trials are in fact real-world testing: real users, real data, outputs that feed into the workflow. Test those first against Article 60(4), point (k): can the output genuinely be reversed and disregarded? If not, redesign the trial before you submit anything. Then choose deliberately between two routes: supervised testing inside a sandbox under Article 57(5) and Article 58(4), or outside a sandbox under Article 60. Plan the six months realistically and decide in advance at which point you will request an extension, since that requires prior notification with a reasoned explanation. Check whether an ethical review is mandatory in your domain and start it in parallel, because Article 60(3) does not exempt you from it.

  1. 01

    Submit the testing plan, obtain approval and register the test

    Draw up a real-world testing plan, submit it to the market surveillance authority, obtain approval, register the test with a Union-wide unique single identification number, and record the division of roles with your deployer.

What to retain

Dated and documented informed consent of test subjects

For every test subject you record freely given informed consent, covering five prescribed information elements, dated, documented, with a copy provided to the subject.

Control and reassessment

  • Oversight during the test, incident reporting and recall procedure

    The market surveillance authority may inspect unannounced. On a serious incident you report, take immediate mitigation or suspend, and you must have a procedure in place in advance for prompt recall of the system.

Public tools

Conditions and exceptions

  • Article 60(1), third subparagraph, leaves Union and national law on real-world testing of high-risk systems related to products under the Annex I harmonisation legislation unaffected. Article 60(4), point (i), contains a law enforcement carve-out: where seeking informed consent would prevent the system from being tested, testing may proceed without consent, provided the testing and its outcome have no negative effect on the subjects and their personal data are deleted after the test. For the systems referred to in Annex III, points 1, 6 and 7, in law enforcement, migration, asylum and border control, registration runs through the secure non-public section of the EU database under Article 49(4), point (d). For the systems referred to in Annex III, point 2, Article 49(5) requires registration at national level.

Official sources and locators

  • EU Artificial Intelligence Act 2024/1689

    European Parliament and Council | original-oj-2024-07-12

    Source locator: Article 60(1)-(4), Article 60(9), Article 113

Version history

  1. v1.0.0

    8 August 2026

    Article 60: testing in real world conditions outside a sandbox

    If you want to test an Annex III high-risk AI system with real people and real outcomes before placing it on the market, a full regime applies: a plan, prior approval by the market surveillance authority, registration, informed consent and a maximum duration.

Execution

From obligation to arranged and demonstrable

Knowing where you stand is step one. Embed AI translates this obligation into a concrete approach for your organisation: scope, ownership, register and evidence.

See the Embed AI approach

For AI agents and integrations

This page and the machine output derive from the same versioned object. Use the API for deterministic filters by role, topic and time.